{"id":"https://openalex.org/A5082855442","orcid":"https://orcid.org/0000-0002-3368-3827","observed_orcids":["https://orcid.org/0000-0002-3368-3827"],"display_name":"Markus A. Queisser","raw_author_names":["Markus A. Queisser","Markus Queisser","Queisser, Markus A."],"full_name":"Markus A. Queisser","works_count":34,"cited_by_count":2859,"summary_stats":{"2yr_mean_citedness":8.0,"h_index":16,"i10_index":17},"ids":{"openalex":"https://openalex.org/A5082855442","orcid":"https://orcid.org/0000-0002-3368-3827","observed_orcids":["https://orcid.org/0000-0002-3368-3827"]},"affiliations":[{"institution":{"id":"https://openalex.org/I111979921","ror":"https://ror.org/000e0be47","display_name":"Northwestern University","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},"years":[2017,2015,2012]},{"institution":{"id":"https://openalex.org/I129975664","ror":"https://ror.org/05cf8a891","display_name":"Albert Einstein College of Medicine","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]},"years":[2009]},{"institution":{"id":"https://openalex.org/I188950975","ror":"https://ror.org/01xsqw823","display_name":"GlaxoSmithKline (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},"years":[2026,2025,2022,2021,2020,2019]},{"institution":{"id":"https://openalex.org/I200763008","ror":"https://ror.org/033eqas34","display_name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen","country_code":"DE","type":"education","lineage":["https://openalex.org/I200763008"]},"years":[2012,2009,2008]},{"institution":{"id":"https://openalex.org/I40120149","ror":"https://ror.org/052gg0110","display_name":"University of Oxford","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},"years":[2017]},{"institution":{"id":"https://openalex.org/I4210106789","ror":"https://ror.org/01e473h50","display_name":"Ludwig Cancer Research","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210106789","https://openalex.org/I4210150094"]},"years":[2017]},{"institution":{"id":"https://openalex.org/I4405268060","ror":"https://ror.org/05mayyh83","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I188950975","ror":"https://ror.org/01xsqw823","display_name":"GlaxoSmithKline (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","ror":"https://ror.org/05mayyh83","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":19,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","count":15,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","count":15,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","count":5,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":3,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":0.00032,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":0.0001204,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","value":6.2e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","value":2.37e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","value":2.11e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.9617320895195007},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.8034025430679321},{"id":"95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","score":0.6061959266662598},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.4590514898300171},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.41421976685523987}],"counts_by_year":[{"year":2008,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2009,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2010,"works_count":3,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":1,"oa_works_count":1,"cited_by_count":62},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":89},{"year":2014,"works_count":1,"oa_works_count":1,"cited_by_count":93},{"year":2015,"works_count":1,"oa_works_count":1,"cited_by_count":101},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":120},{"year":2017,"works_count":3,"oa_works_count":2,"cited_by_count":140},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":159},{"year":2019,"works_count":2,"oa_works_count":2,"cited_by_count":174},{"year":2020,"works_count":3,"oa_works_count":1,"cited_by_count":192},{"year":2021,"works_count":6,"oa_works_count":3,"cited_by_count":217},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":297},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":289},{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":289},{"year":2025,"works_count":5,"oa_works_count":2,"cited_by_count":312},{"year":2026,"works_count":2,"oa_works_count":0,"cited_by_count":267}],"display_name_alternatives":["Markus A. Queisser","Markus Queisser","Queisser, Markus A."],"block_key":"m queisser","works_api_url":"https://api.openalex.org/works?filter=author.id:A5082855442","awards_count":0,"updated_date":"2026-11-08T12:57:04","created_date":"2016-06-24T00:00:00"}